Compare
Stryker Corp vs 3M Co vs Medline Inc. vs Baxter International Inc
| Latest fiscal year | Stryker Corp SYK | 3M Co MMM | Medline Inc. MDLN | Baxter International Inc BAX |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $25.12B | $24.95B | $28.43B | $11.24B |
| Revenue growth (YoY) | +11.2% | +1.5% | +11.5% | +5.7% |
| Gross margin | 64.0% | 39.9% (computed) | 26.4% | 30.1% |
| Operating margin | 19.5% | 18.6% | 7.8% | -2.7% |
| Net margin | 12.9% | 13.0% | 4.1% | -8.5% |
| Net income | $3.25B | $3.25B | $1.16B | -$957.00M |
| EPS (Diluted) | $8.40 | $6.00 | -$0.01 | -$1.87 |
| Operating cash flow | $5.04B | $2.31B | $1.74B | $845.00M |
| Free cash flow | $4.28B | $1.40B | $1.30B | $332.00M |
| Cash & equivalents | $4.01B | n/a | $1.94B | $1.97B |
| Total assets | $47.84B | $37.73B | $38.48B | $20.05B |
| Total liabilities | $25.42B | $32.99B | $19.20B | $13.95B |
| Shareholders' equity | $22.42B | $4.75B | $10.74B | $6.10B |
| Return on year-end equity | 14.5% | 68.5% | 10.8% | -15.7% |
| Shares outstanding | n/a | 530.28M | n/a | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Stryker Corp | 3M Co | Medline Inc. | Baxter International Inc |
|---|---|---|---|---|
| Latest | $25.12B Ended 2025-12-31 | $24.95B Ended 2025-12-31 | $28.43B Ended 2025-12-31 | $11.24B Ended 2025-12-31 |
| 1 year earlier | $22.59B Ended 2024-12-31 | $24.57B Ended 2024-12-31 | $25.51B Ended 2024-12-31 | $10.64B Ended 2024-12-31 |
| 2 years earlier | $20.50B Ended 2023-12-31 | $24.61B Ended 2023-12-31 | $23.23B Ended 2023-12-31 | $10.36B Ended 2023-12-31 |
| 3 years earlier | $18.45B Ended 2022-12-31 | $26.16B Ended 2022-12-31 | n/a | $10.06B Ended 2022-12-31 |
| 4 years earlier | $17.11B Ended 2021-12-31 | $35.35B Ended 2021-12-31 | n/a | $12.15B Ended 2021-12-31 |